Foresight leads GBP2.1m Novel Technologies Holdings Limited funding round
Foresight Group (Foresight), an independent infrastructure and private equity investment manager, is pleased to announce a GBP500,000 growth capital investment into Novel Technologies Holding Limited (NTH), developers of antimicrobial technology SILVERbac. This is the third investment made by the GBP20 million Foresight Scottish Growth Fund which is financed by the Scottish

